Elevated Lp(a) with a small apo(a) isoform in children: Risk factor for the development of premature coronary artery disease

Acta Paediatrica, International Journal of Paediatrics

Volumn 97, Issue 12, 2008, Pages 1653-1657

  Dirisamer, Albert ^a   Widhalm, Harald ^a   Aldover Macasaet, Elsie ^a   Molzer, Sylvia ^a   Widhalm, Kurt ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A; LIPOPROTEIN A;

ADOLESCENT; ADULT; ARTICLE; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; FAMILIAL DISEASE; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL; RISK FACTOR; SCHOOL CHILD; STATISTICAL SIGNIFICANCE;

ADOLESCENT; AGE FACTORS; APOPROTEIN(A); CASE-CONTROL STUDIES; CHILD; COMORBIDITY; CORONARY ARTERY DISEASE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; HYPERCHOLESTEROLEMIA; MALE; PHENOTYPE; PROTEIN ISOFORMS; RISK FACTORS; SEX FACTORS;

EID: 55649089641     PISSN: 08035253     EISSN: 16512227     Source Type: Journal    
DOI: 10.1111/j.1651-2227.2008.00979.x     Document Type: Article

References (38)

1. Danesh J, Collins R, Peto R. L(a) and coronary heart disease: meta-analysis of prospective studies. Circulation 2000 102 : 1082 5.
2. Wild SH, Fortmann SP, Marcovina SM. A prospective case-control study of lipoprotein(a) levels and apo(a) size and risk of coronary heart disease in Stanford Five-City Project participants. Arterioscler Thromb Vasc Biol 1997 17 : 239 45.
3. Klausen IC, Sjol A, Hanson PS, Gerdes LU, Moller L, Lemming L, et al. Apolipoprotein(a) isoforms and coronary heart disease in men: a nested case-control study. Atherosclerosis 1997 132 : 77 84.
4. Dahlen GH, Guyton JR, Attar M, Farmer JA, Kautz JA, Gotto AM Jr. Association of levels of lipoprotein Lp(a), plasma lipids, and other lipoproteins with coronary artery disease documented by angiography. Circulation 1986 74 : 758 65.
5. Shintani S, Kikuchi S, Hamaguchi H, Shiigai T. High serum lipoprotein(a) levels are an independent risk factor for cerebral infarction. Stroke 1993 24 : 965 9.
6. Utermann G. The mysteries of lipoprotein(a). Science 1989 246 : 904 10.
7. Gaubatz JW, Heideman C, Gotto AM Jr., Morrisett JT, Dahlen GH. Human plasma lipoprotein(a): structural properties. J Biol Chem 1983 258 : 4582 9.
8. Utermann G, Menzel HJ, Kraft HG, Duba HC, Kemmler HG, Seitz C. Lp(a) glycoprotein phenotypes: inheritance and relation to Lp(a)-lipoprotein concentrations in plasma. J Clin Invest 1987 80 : 458 65.
9. Brown MS, Goldstein JL. Plasma lipoproteins: teaching old dogmas new tricks. Nature 1987 330 : 113 4.
10. Loscalzo J, Weinfeld M, Fless GM, Scanu AM. Lipoprotein(a), fibrin binding and plasminogen activator. Arteriosclerosis 1990 10 : 240 5.
11. Harpel PC, Gordon BR, Parker TS. Plasmin catalyzes binding of lipoprotein(a) to immobilized fibrinogen and fibrin. Proc Natl Acad Sci USA 1989 86 : 3847 51.
12. McLean JW, Tomlinson JE, Kuang WJ, Eaton DL, Chen EY, Fless GM, et al. cDNA sequence of human apolipoprotein(a) is homologous to plasminogen. Nature 1987 330 : 132 7.
13. Etingin OR, Hajjar DP, Hajjar KA, Harpel PC, Nachman RL. Lipoprotein(a) regulates plasminogen activator inhibitor-1 expression in endothelial cells: a potential mechanism in thrombogenesis. J Biol Chem 1991 266 : 2459 65.
14. Edelberg JM, Gonzales-Gronow M, Pizzo SV. Lipoprotein(a) inhibition of plasminogen activation by tissue-type plasminogen activator. Thromb Res 1990 57 : 155 62.
15. Marcovina SM, Koschinsky ML. Evaluation of lipoprotein(a) as a prothrombotic factor: progress from bench to bedside. Curr Opin Lipidol 2003 14 : 361 6.
16. Lackner C, Cohen JC, Hobbs HH. Molecular definition of the extreme size polymorphism in apolipoprotein(a). Hum Mol Genet 1993 2 : 933 40.
17. Sandholzer C, Hallman DM, Saha N, Sigurdsson G, Lackner C, Csaszar A, et al. Effects of the apolipoprotein(a) size polymorphism on the lipoprotein(a) concentration in 7 ethnic groups. Hum Genet 1991 86 : 607 14.
18. Utermann G. Genetic architecture and evolution of the lipoprotein(a) trait. Curr Opin Lipidol 1999 10 : 133 41.
19. Broeckel U, Hengstenberger C, Mayer B, Holmer S, Martin LJ, Comuzzie AG, et al. A comprehensive linkage analysis for myocardial infarction and its related risk factors. Nat Genet 2002 30 : 210 4.
20. Kraft HG, Windegger M, Menzel HJ, Utermann G. Significant impact of the +93 C/T polymorphism in the aüpolipoprotein(a) gene on Lp(a) concentrations ijn Africans but not in Caucasians: confounding effect of linkage disequilibrium. Hum Mol Genet 1998 7 : 257 64.
21. Rosby O, Berg K. LPA gene: interaction between the apolipoprotein(a) size ('kringle IV' repeat) polymorphism and a pentanucleotide repeat polymorphism influences Lp(a) lipoprotein level. J Intern Med 2000 247 : 139 52.
22. Marcovina SM, Zhang ZH, Gaur VP, Albers JJ. Identification of 34 apolipoprotein(a) isoforms: differential expression of apolipoprotein(a) alleles between American blacks and whites. Biochem Biophys Res Commun 1993 191 : 1192 96.
23. Gaw A, Brown EA, Ford I. Impact of apo(a) length polymorphism and the control of plasma Lp(a) concentrations: evidence for a threshold effect. Arterioscler Thromb Vasc Biol 1998 18 : 1870 6.
24. Sandholzer C, Saha N, Kark JD, Rees A, Jaross W, Dieplinger H, et al. Apo(a) isoforms predict risk for coronary heart disease: a study in six populations. Arterioscler Thromb 1992 12 : 1214 26.
25. Gazzaruso C, Garzaniti A, Buscaglia P, Bonetti G, Falcone C, Fratino P, et al. Association between apolipoprotein(a) phenotypes and coronary heart disease at a young age. J Am Coll Cardiol 1999 33 : 157 63.
26. Lundstam U, Herlitz J, Karlsson T, Linden T, Wiklund O. Serum lipids, lipoprotein(a) level, and apolipoprotein(a) isoforms as prognostic markers in patients with coronary heart disease. J Intern Med 2002 251 : 111 8.
27. Islam S, Gutin B, Smith C, Treiber F, Kamboh I. Association of apolipoprotein(a) phenotypes in children with family history of premature coronary artery disease. Arteriosler Thromb Vasc Biol 1994 14 : 1609 16.
28. Paultre F, Pearson TA, Weil H, Tuck C, Myerson M, Rubin J, et al. High levels of Lp(a) with a small Apo(a) isoform are associated with coronary artery disease in African American and white men. Arterioscler Thromb Vasc Biol 2000 20 : 2619 24.
29. Kronenberg F, Neyer U, Lhotta K, Trenkwalder E, Auinger M, Pribasnig A, et al. The low molecular weight apo(a) phenotype is an independent risk factor for coronary artery disease in hemodialysis patients: a prospective follow-up. J Am Soc Nephrol 1999 10 : 1027 36.
30. Brown SA, Morrisett JD, Boerwinkle E, Hutchinson R, Patsch W. The relation of lipoprotein(a) concentrations and apolipoprotein(a) phenotypes with asymptomatic atherosclerosis in subjects of the atherosclerosis risk in communities (ARIC) study. Arteriosler Thromb 1993 13 : 1558 66.
31. Klausen C, Beisiegl U, Menzel HJ, Rosseneu M, Nicaud V, Faergeman O. Apo(a) phenotypes and Lp(a) concentrations in offspring of men with and without myocardial infarction (the EARS study). Arterioscler Thromb Vasc Biol 1995 15 : 1001 8.
32. Seed M, Hoppichler F, Reaveley D, McCarthy S, Thompson GR, Boerwinkle E, et al. Relation of serum lipoprotein(a) concentrations and apolipoprotein(a) phenotype to coronary heart disease in patients with familial hypercholesterolemia. N Engl J Med 1990 322 : 1494 99.
33. Sandholzer C, Boerwinkle E, Saha N, Tong MC, Utermann G. Apolipoprotein(a) phenotypes, Lp(a) concentration and plasma lipid levels in relation to coronary heart disease in a Chinese population: evidence for the role of the apo(a) gene in coronary heart disease. J Clin Invest 1992 89 : 1040 6.
34. Rodriguez CR, Seman LJ, Ordovas JM, Jenner J, Genest J Jr., Wilson PWF, et al. Lipoprotein(a) and coronary heart disease. Chem Phys Lipids 1994 67-8 : 389 98.
35. Srinivasan SR, Dahlen GH, Jarpa RA, Webber LS, Berenson GS. Racial (black-white) differences in serum lipoprotein(a) distribution and its relation to parental myocardial in children. Circulation 1991 84 : 160 7.
36. Marquez A, Mendoza S, Carrasco H, Hamer T, Glueck CJ. High lipoprotein(a) in children from kindreds with parental premature myocardial infarction. Pediatr Res 1993 34 : 670 4.
37. Wilcken DE, Wang XL, Greenwood J, Lynch J. Lipoprotein(a) and apolipoproteins B and A-1 in children and coronary vascular events in their grandparents. J Pediatr 1993 123 : 519 26.
38. Dirisamer A, Widhalm K. Lipoprotein(a) as a potent risk indicator for early cardiovascular disease. Acta Paediatr 2002 91 : 1313 7.